Portfolio company
Iolyx Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops immunomodulatory medicines to treat ocular inflammation and autoimmune eye diseases for patients worldwide.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
Eyexora
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
Dualyx
This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.
Oculis
This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.
Tavo Biotherapeutics
The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.
Healome Therapeutics
The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.
Viridiantherapeutics
This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.
Nuvig
Nuvig Therapeutics develops immunomodulatory medicines to treat patients with chronic inflammatory and autoimmune diseases.
